Mon, Mar 2, 2015, 4:53 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ADVANCED CELL TECH Message Board

beareclawe 395 posts  |  Last Activity: 44 minutes ago Member since: Jan 10, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Do the Math

    by hschlauch Dec 3, 2014 11:39 AM
    beareclawe beareclawe Feb 25, 2015 4:21 PM Flag

    Re: Bye Bye OTC, hello Nas. Tomorrow is a new dawn!!!

    " They will rise like a phoenix from the ashes under the designation, Ocata Therapeutics, and fleece another untapped source (NASDAQ) of funding."

    csr1223 • Sep 12, 2014 12:22 PM
    Ocata Therapeutics aka "Medicine Man"
    From Paul Knoepfler's stem cell blog: The latest development is a move to change the company’s name to Ocata Therapeutics. I asked Bob Lanza about the name changed and he told me that “Ocata is a native American (Huron) word for ‘medicine man’.” Cool name. I agree with Paul Knoepfler quoted above. Cool name! BTW, Paul disclosed that he recently bought stock in Ocata Therapeutics for the long haul. Things are starting to look very very good.

    Yup, 'Things are starting to look very very good.' With corporate rebranding, ACTC can shed negative images of their past. They will rise like a phoenix from the ashes under the designation, Ocata Therapeutics, and fleece another untapped source (NASDAQ) of funding.

    : ) Let the r e a l games begin !

  • Reply to

    OT: A DIFFERENT TASTE FOR FIGHTER PILOT

    by elk_1l Feb 2, 2015 10:58 AM
    beareclawe beareclawe Feb 25, 2015 3:20 PM Flag

    Re: ........ eat raw asparagus for the next 25 years.

    Citations:

    "As a Lutheran ...."

    FIGHTERPILOT • Oct 18, 2011 10:10 AM
    "European courts are likely to be more logical than ideological"
    The pope used to be my neighbor and there were other neighbors like judges who .......... very ideological. As a Lutheran growing up in a Catholic ( Bavaria) region, I know going against the church is not good for your business.

    "might be willing to settle with you. With him NEVER EVER. "

    fighterpilot • Mar 28, 2014 3:20 PM
    might be willing to settle with you. With him NEVER EVER. His character is more than rotten. Too rotten to cure. I just give you one little example. My father after the war, despite the fact that he was a high ranking army officer was treated by our former enemies like the British and the Americans with utmost respect. Maybe you can come to a valid conclusion leaving the likes aside.

    : ( Methinks asparagus consuming lutherans are 'NEVER EVER' christians.

  • Reply to

    OT: A DIFFERENT TASTE FOR FIGHTER PILOT

    by elk_1l Feb 2, 2015 10:58 AM
    beareclawe beareclawe Feb 25, 2015 2:54 PM Flag

    Re: I build the garden house on a favorite spot of mine, terrific view and nicely protected by large, beautiful rock formations. Combine this inspiring setting with fresh salad and asparagus .....

    FIGHTERPILOT • May 11, 2011 12:57 PM
    Below .20
    Those times are gone and below .30 will not last that much longer. NO BRAINER Anticipation alone will drive the SP higher. Anticipation of a game changer. Just picture this: With every patient, results can be seen in a short time, if the results are positive, overwhelming evidence will accumulate rapidly and lead to FDA approval speed you never have seen before. These are open trials !!!!!! Open trials with results under a microscope. Compare with seeds in your garden, when the plant breaks through the soil and is growing to your favorite vegetable you have with your steak, only totally derailed bashers, super idiots, like the ones we have on this MB, will call this a failure. Bashers are toast !!!! No Brainer !!!!!

    : ) Patiently waiting for the sequel to his infamous ' Below .20 ' prophecy.

  • Reply to

    OT: A DIFFERENT TASTE FOR FIGHTER PILOT

    by elk_1l Feb 2, 2015 10:58 AM
    beareclawe beareclawe Feb 25, 2015 2:42 PM Flag

    Re: OT

    The fuhrer prefers consuming 'raw asparagus.'

    "......eat raw asparagus for the next 25 years."

    FIGHTERPILOT • Jan 27, 2011 12:50 PM
    elevation

    nice encouragement and I treasure folks like your parents.

    There is another thing I like to mention, I build the garden house on a favorite spot of mine, terrific view and nicely protected by large, beautiful rock formations. Combine this inspiring setting with fresh salad and asparagus ..... and life is not getting that much better. I guess I will go there for meditation, lay in the hammock and eat raw asparagus for the next 25 years. :-) :-) Will see if it gets in my system faster than booze. LOL

    : )

  • beareclawe beareclawe Feb 25, 2015 2:06 PM Flag

    Re: PICK ONE, JUST ONE ........

    Citation:

    ADVANCED CELL TECHNOLOGY, INC.
    11/10/14 Form 10-Q

    (excerpts)

    Changes in U.S. patent law and in patent law in other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our products.

    As is the case with other biotechnology companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biotechnology industry involve both technological and legal complexity, and is therefore obtaining and enforcing biotechnology patents is costly, time-consuming and inherently uncertain. In addition, the United States has recently enacted and is currently implementing wide-ranging patent reform legislation. Recent U.S. Supreme Court rulings and rulings from the European Patent Office Board of Appeals have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations, including potentially relating to the patentability of cells and tissues generated from hESC lines, and their uses as therapeutics. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts, and the USPTO, and equivalents bodies in other major markets, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future.

    We may not be able to adequately defend against piracy of intellectual property in foreign jurisdictions.

    Considerable research in the areas of stem cells, cell therapeutics and regenerative medicine is being performed in countries outside of the United States, and a number of potential competitors are located in these countries. The laws protecting intellectual property in some of those countries may not provide adequate protection to prevent our competitors from misappropriating our intellectual property. Several of these potential competitors may be further along in the process of product development and also operate large, company-funded research and development programs. As a result, our competitors may develop more competitive or affordable products, or achieve earlier patent protection or product commercialization than we are able to achieve. Competitive products may render any products or product candidates that we develop obsolete.

    : )

    : )

  • Reply to

    Thanks Bill Caldwell, Rabin, and Wooten

    by jssflash Feb 25, 2015 1:13 PM
    beareclawe beareclawe Feb 25, 2015 1:26 PM Flag

    Re: Thanks.........

    Citations:

    The National Law Review
    SEC Targets Corporate Insiders for Failing to Promptly Disclose Stock Transactions
    posted on: Thursday, September 18, 2014
    (excerpt)
    3. On May 31, 2012, the Commission charged Advanced Cell with violating Sections 5(a) and 5(c) of the Securities Act and Section 13(a) of the Exchange Act and Rule 13a thereunder. On December 30, 2013, the United States District Court for the Middle District of Florida approved a settlement between the Commission and Advanced Cell pursuant to which Advanced Cell was permanently enjoined from future violations of Sections 5(a) and 5(c) of the Securities Act and Section 13(a) of the Exchange Act and Rule 13a thereunder and was ordered to pay $3,500,000 in disgorgement and $586,619 in prejudgment interest. Advanced Cell is currently paying those amounts through a payment plan, with the final payment of $681,104.16 due on April 15, 2015.

    Also, refer to:
    11/10/14 Form 10-Q
    6. ACCRUED SETTLEMENT
    SEC Civil Action
    SEC Section 16 Investigation

    ......................................................

    ADVANCED CELL TECHNOLOGY, INC.
    June 6, 2014 Form 8-K
    Item 1.01 Entry into a Material Definitive Agreement.
    Lawsuit Settlement

    (excerpt)
    On June 4, 2014, Advanced Cell Technology, Inc. (the “Company”) entered into a settlement agreement .....

    Issue to Aronson 269,766,667 shares of the Company’s common stock; Issue to Gorton 33,133,333 shares of the Company’s common stock; and Issue 68,266,667 shares of the Company’s common stock to Herron, 8,533,333 shares of the Company’s common stock to Miller/Steele, and 4,300,000 shares of the Company’s common stock to Bourke, in each case as payment in full satisfaction of any purported obligation on the part of the Company to pay any legal fees incurred by each of Aronson and Gorton in connection with their respective enforcement of the terms of their warrants.

    : )

  • Reply to

    Thanks Bill Caldwell, Rabin, and Wooten

    by jssflash Feb 25, 2015 1:13 PM
    beareclawe beareclawe Feb 25, 2015 1:20 PM Flag

    Re: Thanks .........

    Citations:

    Lanza: "Any treatment might not be ready for FDA approval until 2020..."

    Tuesday, October 14, 2014
    Published study shows: ACT treatment restores some sight
    By Lisa Eckelbecker TELEGRAM & GAZETTE STAFF
    (excerpt)
    New medical treatments generally must undergo three phases of human study to demonstrate safety, proper dosing and efficacy before the Food and Drug Administration will approve them for sale. In addition to its phase 1 study in the United States, Advanced Cell has been conducting a phase 1 study of its RPE cells in patients in the United Kingdom.

    "We treated the last UK patients last month, and they also have not seen any safety issues related to the transplanted tissues themselves, either," Dr. Lanza said. Advanced Cell now hopes to launch a 100-patient, phase 2 study in Stargardt's patients by the end of the year, according to Dr. Lanza. A second, smaller phase 2 study in patients with age-related macular degeneration would follow, he said. Any treatment might not be ready for FDA approval until 2020, Dr. Lanza said.

    Schwartz: "It's not ready. Maybe in a few years. Maybe not. We have to wait and see. The jury is way out still."

    npr
    Embryonic Stem Cells Restore Vision In Preliminary Human Test
    Rob Stein
    October 14, 2014
    (excerpt)
    For his part, Schwartz says he's just trying to help blind people see better. But he cautions that this work is still at a very early stage.

    "I don't want patients to come in to their doctor saying, 'Hey, I heard about the stem cells on the radio and I'd really like to get that treatment done, and what do you think?' " he says. "It's not ready. Maybe in a few years. Maybe not. We have to wait and see. The jury is way out still."

    Wotton: "Over in Europe we believe we might be able to get that product to market towards the end of 2018, but we are targeting 2019."

    YouTube
    Dauphin Investor
    Roadshow: Ocata Therapeutics, Inc. (IPO)
    Published on Dec 6, 2014

    : )

  • beareclawe beareclawe Feb 25, 2015 1:09 PM Flag

    Re: Its been fun watching them cycle thru their aliases today, some kicking and screaming, some claiming to be longs and others just begging for attention.

    It's hard to defeat an opponent when the demon is living inside your head.

    The Substance Abuse and Mental Health Services Administration (SAMHSA) has an online guide to help anyone who needs it find treatment programs near them. It also runs a 24-hour, toll-free information line at 1-800-662-HELP (4357).

    : ) Methinks thou dost protest too much.

  • beareclawe beareclawe Feb 25, 2015 12:51 PM Flag

    Re: I am taking a break until Uplist is done

    fighterpilot • 2 hours 5 minutes ago
    Will be back tomorrow
    Watch the SP after my opening remarks at the bell

    : ) If you're not a person of your word(s) ........ What does that make you ?

  • Reply to

    Will this be the payoff for 8

    by booskiadam Feb 25, 2015 7:08 AM
    beareclawe beareclawe Feb 25, 2015 12:16 PM Flag

    Re: More poopy from bearpoopy.

    I'm beareclawe, and my beare thoughts are not your thoughts, neither are your ways my beare ways. As the celestial heavens are higher than the earth, so are my beare ways higher than your ways, and my beare thoughts than your thoughts.

    : ) That's bearecraft.

  • Reply to

    Will this be the payoff for 8

    by booskiadam Feb 25, 2015 7:08 AM
    beareclawe beareclawe Feb 25, 2015 11:52 AM Flag

    Re: Sorry if you misunderstood my posts, thinking I am desperate.....

    Anxious and desperate. Sheeple like yourself have selective retention recall.

    Re: .... my ultimate goal of being independently wealthy but in due time my man.

    Yes, yess, yessss........ affluence equates to freedom. Freedom to devote three years of my youth circumnavigating the world under sails. Now, being much older and wiser..... I devote 'bout 40% of my time on water and 60% on land.

    Re: Try not to be so judgemental, your anger .....

    'Sorry if you misunderstood my posts.'

    : ) KA-CHING, KA-CHING, KACHINA$

  • Reply to

    Will this be the payoff for 8

    by booskiadam Feb 25, 2015 7:08 AM
    beareclawe beareclawe Feb 25, 2015 7:53 AM Flag

    Re: Will this be the payoff for 8 years of patience and accumulation?

    What advantage is there being a long term, anxious and desperate, story stock sheeple investor ? What urgency existed when you decided to buy ACTC, and go long ? Didn't want to mi$$ the boat, bus, plane, or train ? Surely, it couldn't have been ACTCs business model ? Did you allow the rabidly optimistic, unconscionable, and conjecture-based cloud your judgement ?

    : )

  • beareclawe beareclawe Feb 24, 2015 5:43 PM Flag

    Re: If you're not a person of your word(s) ........ What does that make you ?

    Methinks 'em asparagus consuming lutherans are 'NEVER EVER' christians.

    fighterpilot • Mar 28, 2014 3:20 PM
    might be willing to settle with you. With him NEVER EVER. His character is more than rotten. Too rotten to cure. I just give you one little example. My father after the war, despite the fact that he was a high ranking army officer was treated by our former enemies like the British and the Americans with utmost respect. Maybe you can come to a valid conclusion leaving the likes aside.

    : (

  • beareclawe beareclawe Feb 24, 2015 12:01 PM Flag

    Re: fighterpilot • Feb 11, 2015 8:27 PM
    I am taking a break until Uplist is done
    See ya alligator

    "I am taking a break until Uplist is done"

    Citations:

    fighterpilot • 17 hours ago
    Will be back on Thursday !!!
    Expect a nice jump :-)

    fighterpilot • 17 hours ago
    Bump for keep

    : ) If you're not a person of your word(s) ........ What does that make you ?

  • Reply to

    OCAT 2014 Highlights

    by dpeters798 Feb 22, 2015 11:36 AM
    beareclawe beareclawe Feb 24, 2015 3:57 AM Flag

    Re: Red thumb it all you want but it's pretty simple. Oct 14th comes before Nov. 24th. It's only a calendar folks, don't be afraid....

    karl.todd78 • 8 hours ago
    Ok Beare, you were right and I was wrong and if you would like to look back through all my old comments(since that's your thing,) you will find this is not the first time I've admitted when I was wrong...

    : )

  • beareclawe beareclawe Feb 24, 2015 3:43 AM Flag

    Re: No products to sell until .......

    Citations:

    "Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA ..."

    Reuters Edition
    Tue Mar 2, 2010 9:00am EST
    Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt`s Macular Dystrophy

    "Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation from the European Medicines Agency."

    Press Release
    Ocata Therapeutics, Inc.
    November 24, 2014
    Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation from the European Medicines Agency. Advanced Medicinal Product Designation Granted for its Retinal Pigment Epithelium Programs, in clinical trials for Stargardt’s Macular Degeneration (SMD) and dry Age-related Macular Degeneration (AMD).

    : )

  • beareclawe beareclawe Feb 24, 2015 3:14 AM Flag

    Re: We should soon be hearing from ............. Fighter again

    Yeah, he gave me a thumbs down.

    fighterpilot • Apr 11, 2014 Apr 11, 2014 6:00 AM
    And by the way, my wholesale removal of posts is a response to your endless obsessed stalking and exploitation of any information about myself and my family. I just wish that my father who has died many years ago and was about as remote to any war crimes as it can get , from location to his character and mindset about Hitler, can put a curse on you from heaven. And further, not every German was born in Germany and this might just include me. FOR YOUR INFORMATION TO EXPLOIT AND DISTORT.

    Methinks thou dost protest too much. A 'Yes' or 'No' would suffice.

    : ) Pixels are mightier than the sword.

  • beareclawe beareclawe Feb 23, 2015 8:19 PM Flag

    Re: We should soon be hearing from ............. Fighter again

    This inquiring mind would like to know if fighterpilot's relatives were ever involved with atrocities committed against humanity during WWII ? I suspect there's more going on here than meets the eye for the altruistic, genetically superior, german intelligence-trained being.

    : (

  • beareclawe beareclawe Feb 23, 2015 6:57 PM Flag

    Re: karl.todd78 • 22 hours ago
    And both of those OCT 14th statements were made before ATMP designation was granted, but I appreciate you posting them and saving me the work...

    What country/agency issues ATMPs ? Wotton's comment would apply to the ATMP issue.

    : )

  • beareclawe beareclawe Feb 23, 2015 6:52 PM Flag

    Re: So exactly what is wrong with my statement?

    Citations:

    Lanza: "Any treatment might not be ready for FDA approval until 2020..."

    Tuesday, October 14, 2014
    Published study shows: ACT treatment restores some sight
    By Lisa Eckelbecker TELEGRAM & GAZETTE STAFF
    (excerpt)
    New medical treatments generally must undergo three phases of human study to demonstrate safety, proper dosing and efficacy before the Food and Drug Administration will approve them for sale. In addition to its phase 1 study in the United States, Advanced Cell has been conducting a phase 1 study of its RPE cells in patients in the United Kingdom.

    "We treated the last UK patients last month, and they also have not seen any safety issues related to the transplanted tissues themselves, either," Dr. Lanza said. Advanced Cell now hopes to launch a 100-patient, phase 2 study in Stargardt's patients by the end of the year, according to Dr. Lanza. A second, smaller phase 2 study in patients with age-related macular degeneration would follow, he said. Any treatment might not be ready for FDA approval until 2020, Dr. Lanza said.

    Schwartz: "It's not ready. Maybe in a few years. Maybe not. We have to wait and see. The jury is way out still."

    npr
    Embryonic Stem Cells Restore Vision In Preliminary Human Test
    Rob Stein
    October 14, 2014
    (excerpt)
    For his part, Schwartz says he's just trying to help blind people see better. But he cautions that this work is still at a very early stage..... "I don't want patients to come in to their doctor saying, 'Hey, I heard about the stem cells on the radio and I'd really like to get that treatment done, and what do you think?' " he says. "It's not ready. Maybe in a few years. Maybe not. We have to wait and see. The jury is way out still."

    Wotton: "Over in Europe we believe we might be able to get that product to market towards the end of 2018, but we are targeting 2019."

    YouTube
    Dauphin Investor
    Roadshow: Ocata Therapeutics, Inc. (IPO)
    Published on Dec 6, 2014

    : )

ACTC
6.98+0.18(+2.65%)Nov 13 12:19 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.